美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

三倍做多标普生物-Direxion

166.47

+17.4311.69%

盘后：165.60-0.8704-0.52%19:59 EST

成交量：51.46万

成交额：8,348.16万

市值：5.70亿

市盈率：- -

高：168.04

开：157.98

低：156.69

收：149.04

52周最高：198.18

52周最低：32.55

股本：342.45万

流通股本：342.45万

量比：0.77

换手率：15.03%

股息：1.34

股息率：0.81%

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

概念

ETF&股票定投概念+1.81%

资金流向

资金流入：

资金流出：

新闻资讯

一批制造公众用药焦虑，引导购买高端医疗保险的账号被依法处置

山东新华制药股份(00719)终止收购挪亚圣诺(太仓)生物科技有限公司股权

长春高新：聚焦生物医药主业、深化创新驱动

【券商聚焦】中信证券：商保有望成为医疗健康产业支付端的核心增量

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/LABU"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"三倍做多标普生物-Direxion","latestPrice":166.47,"timestamp":1770411600000,"preClose":149.04,"halted":0,"volume":514622,"hourTrading":{"tag":"盘后","latestPrice":165.5996,"preClose":166.47,"latestTime":"19:59 EST","volume":2147,"amount":355810.367,"timestamp":1770425990968,"change":-0.8704,"changeRate":-0.005229,"amplitude":0.006187},"delay":0,"changeRate":0.11694847020933982,"floatShares":3424486,"shares":3424486,"eps":0,"marketStatus":"休市中","change":17.43,"latestTime":"02-06 16:00:00 EST","open":157.98,"high":168.0401,"low":156.689,"amount":83481646.33569999,"amplitude":0.076161,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":149.04,"sharesOutstanding":3424486,"nav":149.234,"aum":511051227.01,"dividendRate":0.008058,"bidAskSpread":0.002508,"preHourTrading":{"tag":"盘前","latestPrice":155.83,"preClose":149.04,"latestTime":"09:25 EST","volume":11314,"amount":1745765.81332,"timestamp":1770387916532,"change":6.79,"changeRate":0.045558,"amplitude":0.024826},"postHourTrading":{"tag":"盘后","latestPrice":165.5996,"preClose":166.47,"latestTime":"19:59 EST","volume":2147,"amount":355810.367,"timestamp":1770425990968,"change":-0.8704,"changeRate":-0.005229,"amplitude":0.006187},"volumeRatio":0.765017,"impliedVol":0.979,"impliedVolPercentile":0.7769},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":3424486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.765017,"shares":3424486,"dividePrice":1.3414,"high":168.0401,"amplitude":0.076161,"preClose":149.04,"low":156.689,"week52Low":32.55,"pbRate":"--","week52High":198.18,"institutionHeld":0,"latestPrice":166.47,"eps":0,"divideRate":0.008058,"volume":514622,"delay":0,"ttmEps":0,"open":157.98,"prevYearClose":159.39,"prevWeekClose":165.86,"prevMonthClose":165.86,"prevQuarterClose":159.39},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609459639","title":"一批制造公众用药焦虑，引导购买高端医疗保险的账号被依法处置","url":"https://stock-news.laohu8.com/highlight/detail?id=2609459639","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609459639?lang=zh_cn&edition=fundamental","pubTime":"2026-02-06 20:23","pubTimestamp":1770380580,"startTime":"0","endTime":"0","summary":"来源：北京商报\n　　2月6日，北京商报记者了解到，近期，中央网信办会同国家医保局深入整治涉医药集中带量采购的网上虚假不实信息，依法依约处置一批污名集采、制造焦虑、误导公众的账号。根据通报的典型案例，微博账号“成都XXX”，抖音账号“琼波XX”“亮晶晶的XX”等，歪曲国家政策，编造“进口药集体退出中国”等不实信息，煽动网民对原研药与仿制药的对立情绪，其中部分账号旨在制造公众用药焦虑，引导公众购买相关保健品、高端医疗保险，或诱导公众到特定的互联网平台购药。涉及的账号已被依法依约采取处置措施。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：曹睿潼","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-02-06/doc-inhkwssf2096736.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","BK4581","XLV","BK4585","LABU","XBI"],"gpt_icon":0},{"id":"2609569452","title":"山东新华制药股份(00719)终止收购挪亚圣诺(太仓)生物科技有限公司股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2609569452","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609569452?lang=zh_cn&edition=fundamental","pubTime":"2026-02-06 17:50","pubTimestamp":1770371401,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份(00719)发布公告，有关本公司与挪亚圣诺(欧洲)公司签署《股权收购意向协议》。股权收购意向协议仅系各方经友好协商达成的初步意向，然而，经进一步讨论及磋商后，订约方未能就正式协议的条款及条件达成共识。本公司因此并无就该项目订立正式协议，该项目亦不会进行。故此，本公司已决定终止该等股权收购意向协议。终止《股权收购意向协议》系本公司审慎研究后作出的决定，不会影响本公司现有生产经营活动，也不会对本公司的发展造成不利影响，不存在损害本公司及全体股东，特别是中小股东利益的情形。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402599.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","00719","BK4585","BK1515","BK4588","LABU","159837"],"gpt_icon":0},{"id":"2609563345","title":"长春高新：聚焦生物医药主业、深化创新驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2609563345","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609563345?lang=zh_cn&edition=fundamental","pubTime":"2026-02-06 16:24","pubTimestamp":1770366259,"startTime":"0","endTime":"0","summary":"证券之星消息，长春高新(000661)02月06日在投资者关系平台上答复投资者关心的问题。投资者提问：安科生物无论是产品能力还是盈利能力都已经远超公司十倍不止,请问公司管理层如何看待这一翻转？长春高新回复：感谢您对公司的关注。公司目前虽然因为新品布局、全球化拓展带来短期投入加大，阶段性影响净利润，但管理层始终希望可以通过聚焦生物医药主业、深化创新驱动，持续提升公司核心竞争力，最终实现高质量稳健发展，谢谢！为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260206/32003747.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0075","BK0188","BK0028","399441","161726","BK0057","BK4585","BK0046","BK0239","LABU","BK4588","000661"],"gpt_icon":0},{"id":"2609536060","title":"【券商聚焦】中信证券：商保有望成为医疗健康产业支付端的核心增量","url":"https://stock-news.laohu8.com/highlight/detail?id=2609536060","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609536060?lang=zh_cn&edition=fundamental","pubTime":"2026-02-06 08:31","pubTimestamp":1770337883,"startTime":"0","endTime":"0","summary":"下一阶段，该机构认为商保综合服务提供商有望解决保司端人才、数据制约，打开创新药械企业创新价值兑现面临的结构性瓶颈，进一步助推商业健康险行业边际加速发展。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250106/NGZhNmEwMzJkNDhkNWE0NjE0NjM0MTA4NTA5NzI5NDQz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/NGZhNmEwMzJkNDhkNWE0NjE0NjM0MTA4NTA5NzI5NDQz.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1974659","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131003.USD","BK0028","BK4581","BK4585","BK1147","BK0276","LU1794554557.SGD","BK0196","LU1255011170.USD","LU1064130708.USD","LU1997245177.USD","LU2495084118.USD","LU1720050803.USD","BK1516","BK0012","06030","LU0405327494.USD","LU2289578879.USD","BK1521","LU1328615791.USD","BK1564","LU1997245094.SGD","LU1997244956.HKD","BK0183","BK4588","600030","XLV","LU1655091616.SGD","LU2148510915.USD","LABU","XBI","LU0405327148.USD","159760","BK0188"],"gpt_icon":0}],"pageSize":4,"totalPage":40,"pageCount":1,"totalSize":158,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/LABU\",params:#limit:6,delay:false,,,undefined,":[{"market":"US","name":"ETF&股票定投概念","bkCode":"BK4585","id":"package_us_concept_etf&gpdt","changeRate":0.018131},{"market":"US","name":"碎股","bkCode":"BK4588","id":"package_us_concept_sg","changeRate":0.018143}]}}